Last updated: July 12, 2026

Application No. 19/361,604

Untitled Application

Unknown

Filed

Priority

Oct 21, 2024 — provisional 63/709,791 +2 more

Examiner

MOORE, JOHN DAVID

Art Unit

Tech Center

PharmaEssentia Corporation

Assignee

Pharmaessentia Corporation

OA Round

1 (Non-Final)

Interview Optional

— +22.3% interview lift. Examiner has a relatively high allowance rate (67%); +22.3% interview lift. A written response may suffice.

Based on 48 resolved cases, 2023–2026

Examiner Intelligence

MOORE, JOHN DAVID View full profile →

Grants 67% — above average

Career Allowance Rate

32 granted / 48 resolved

+6.7% vs TC avg

Strong +22% interview lift

Without

With

+22.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 6m

Avg Prosecution

28 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

81.2%

+41.2% vs TC avg

§102

7.4%

-32.6% vs TC avg

§112

9.8%

-30.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 48 resolved cases

Prosecution Timeline

May 19, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/843,462

Patent 12674154

FUSION PROTEIN THAT IMPROVES GENE EDITING EFFICIENCY AND APPLICATION THEREOF

4y 0m to grant Granted Jul 07, 2026

17/753,491

Patent 12648968

FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE

4y 3m to grant Granted Jun 09, 2026

18/136,774

Patent 12644119

REGULATION OF TRANSLATION OF EXPRESSED GENES

3y 1m to grant Granted Jun 02, 2026

18/225,482

Patent 12629451

METHOD FOR MANUFACTURING EXTRACELLULAR MATRIX COMPOSITION

2y 10m to grant Granted May 19, 2026

19/228,566

Patent 12616191

SYSTEMS AND METHODS FOR REVERSIBLE CRYOPRESERVATION

11m to grant Granted May 05, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

67%

Grant Probability

89%

With Interview (+22.3%)

3y 6m

Median Time to Grant

Low

PTA Risk

Based on 48 resolved cases by this examiner. Grant probability derived from career allowance rate.